HPA Axis: New Clinical Developments

FP21-2

Increased Prevalence of Intracranial Meningiomas in Patients With ACTH-Independent Macronodular Adrenal Hyperplasia
Guilherme Asmar Alencar, Berenice B Mendonca, Mirian Y Nishi, Ana Claudia Latronico, Madson Q. Almeida, Antonio Marcondes Lerario and Maria Candida Barisson Villares Fragoso

FP21-3

Hypothalamic Pituitary Dysfunction Amongst Nasopharyngeal Cancer Survivors: An Increased Risk With The Use Of Concurrent Chemo-Irradiation
Jeyakantha Ratnasingam, N Karim, Alexander Tong Boon Tan, Shireene Vethakkan, Karen Choong and Siew Pheng Chan

FP21-4

Continuous Subcutaneous Hydrocortisone Infusion (CSHI) Improves Quality-of-Life in Addison's Disease (AD)
Marianne Oksnes, Sigridur Bjornsdottir, Magnus Isaksson, Roy Miodini Nilsen, Siri Carlsen, Olle Kämpe, Anna-Lena Hulting, Sophie Bensing, Eystein Sverre Husebye and Kristian Lovas

FP21-5

Endometrial Effects of Long-Term Mifepristone (MIFE) Treatment of Cushing's Syndrome: Results From the Seismic Studies
Ty Brian Carroll, Olga Ioffe, Irving M Spitz, Coleman Gross, David Cram and Amir Hekmat Hamrahian

FP21-6

Ovarian Hormone Suppression With Estradiol Add-Back Therapy in Premenopausal Women Reduces Dynamic HPA Axis Activity
Kathleen M Gavin, Ellie Gibbons, Anne Stavros, Tammie Nakamura, Karen L Villalon and Wendy M Kohrt